Unmet needs in Burkitt lymphoma: diagnosis and treatment

Sam Mbulaiteye, MBChB, M.Phil., M.Med., National Institutes of Health, Bethesda, MD, gives an overview of unmet needs in the diagnosis and treatment of Burkitt lymphoma, and further highlights the value of novel targeted therapies and technologies. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.